Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-05-23 @ 8:59 AM
Study NCT ID:
NCT05388760
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-05
First Post:
2022-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
Sponsor:
LEO Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LP0162-1335
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None